White & Case Scores for Pfizer in Lyrica Patent Row

, The Litigation Daily

   | 0 Comments

Pfizer Inc. and its lawyers at White & Case fended off a major challenge from generic rivals on Thursday, persuading an appeals court that patents for the blockbuster painkiller Lyrica give the company exclusive rights to sell the drug through the end of 2018.

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article# 1202641908480

Thank you!

This article's comments will be reviewed.